Tag:
Rotarix
Latest Headlines
Latest Headlines
U.K. vaccine expansion a boon for GSK and Merck
Sales of GlaxoSmithKline's rotavirus vaccine Rotarix and Merck's shingles vaccine Zostavax will be buoyed by their inclusion on the U.K. national immunization schedule.
GSK's rotavirus vaccine selected for British program
British health officials selected GlaxoSmithKline's Rotarix vaccine for the country's first routine rotavirus immunization program.
20 Top-selling Vaccines -- H1 2012
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales.
The 20 top-selling vaccines in H1 2012
As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales. Take a look at the full list >>
Japan ushers in big meds from AZ, GSK, Merck
Japanese health regulators spread some happiness yesterday, granting marketing approval to several major Big Pharma products. AstraZeneca, GlaxoSmithKline, and Merck each got the nod for a key drug
GSK adds bowel risk to Rotarix label
Some evidence has cropped up indicating that GlaxoSmithKline's infant vaccine Rotarix may boost the risk of a rare but potentially fatal bowel problem. It's intussusception--a condition in which the
FDA warns on possible safety issue with GSK's Rotarix
The FDA has raised a red safety flag on GlaxoSmithKline's rotavirus vaccine Rotarix. The agency is reporting that preliminary data from a new study indicates that the vaccine could raise the risk of
FDA takes brakes off GSK's Rotarix
Rotavirus vaccines are in the clear. The FDA has decreed that both GlaxoSmithKline's ( NYSE: GSK ) Rotarix and Merck's ( NYSE: MRK ) Rotateq are safe despite their contamination with DNA from a pig virus
Drugmakers: Trypsin likely culprit in Rotavirus vax contamination
Rotavirus vaccine makers say they believe a contaminant of the pig enzyme trypsin, used in the vaccine's manufacture, is responsible for the pig virus detected in both GlaxoSmithKline's ( NYSE: GSK )
FDA panel: Rotavirus vaccines worth any PCV risk
It's a rotavirus reprieve. An FDA panel backed continued use of vaccines against the diarrhea-causing germ from both Merck ( NYSE: MRK ) and GlaxoSmithKline ( NYSE: GSK ), in spite of trace contamination
